CVE-2026-103523 — CVE-2026-103523
Thelia v2.6.0 contains an open redirect vulnerability in its address creation workflow. After a user accesses a crafted URL and successfully submits the “Add New Address” form, the application redirects them to the URL specified in the `next` parameter. Because the application does not validate whether the destination belongs to the same origin or an approved allowlist, an attacker can supply an arbitrary external URL and redirect users to an attacker-controlled website.
Who exploits it and how urgent it is
A 0–100 score combining confirmed exploitation, ransomware and APT use, public exploits, EPSS and severity.
How the score was calculated
- EPSS 0.2% (30-day exploitation probability)+1
The score orders the patch queue; it does not replace your asset context (internet exposure, criticality, compensating controls).
Triage
Is it exploited, how likely is exploitation, what does it touch, and how severe do the sources call it.
Remediation
Fixes and mitigations documented by the sources — linked to the original advisory.
No fix documented by the sources we poll. That does not mean none exists: check the vendor advisory.
First 24 hours
Ordered from the record’s own fields — exposure first, because you cannot patch what you have not found. A rule-generated starting point.
- Identify exposed assets running the affected vendor/product/version combinations (Thelia Thelia).
- No fix documented in the sources: reduce exposure and monitor the vendor advisory.
- Search available logs for exploit probes, errors and authentication anomalies.
Affected scope
Vendor, product and versions as the sources word them.
EPSS over time FIRST
Oct 13, 2026 → Oct 14, 2026 · 2 reading(s) · max 0.18%
Detection
Read off the CVSS vector and the weakness class. Starting points, not tested rules.
- Not enough vector or weakness data: use the affected application’s logs as a starting point.
Timeline
What happened to this CVE, newest first.
- 2026
- Record published
- Affected products added · thelia/thelia
- Source status changed · → Deferred
- Record created in this database
- CVE published
Source activity
Repeated readings are counted rather than listed.
- 1× Official description updated · Oct 13, 2026 – Oct 13, 2026
References
1 on the record
Elsewhere on this site
Related CVEs (same products)
- Medium CVE-2026-109396 Thelia before 3.1.2 and 3.2.x before 3.2.1 CSV Formula Injection via Exports 3d
- High CVE-2026-109397 Thelia before 3.1.2 and 3.2.x before 3.2.1 File Upload RCE via Filename Trailing Space 3d
- High CVE-2026-107248 CVE-2026-107248 3d
- Medium CVE-2026-103537 CVE-2026-103537 3d
- Medium CVE-2026-103528 CVE-2026-103528 3d
- High CVE-2026-103535 CVE-2026-103535 3d
Not in any source we poll
Listed rather than left blank: an empty field and an unmeasured one look identical on screen, and only one is a reason to look elsewhere.
- No CVSS score published by NVD, the CNA, CISA or GitHub so far.
- No fixed version, patch or mitigation documented.
- No CISA SSVC assessment.
- No CWE classification.
- No confirmed IOCs, IP addresses, domains, file hashes, or malware artifacts supplied.
- No organization-specific asset inventory, compensating-control status, or patch deployment evidence supplied.
- No exploit packet captures, log samples, or incident case IDs supplied.
Answered from this record
Text assembled only from the fields above — no additional claims.
What should defenders know first?
CVE-2026-103523 is "CVE-2026-103523", rated Unknown. It affects Thelia (Thelia); versions are in the scope table. It is not in CISA KEV, which does not rule out exploitation. EPSS 0.18% estimates the probability of exploitation in 30 days; neither replaces your asset context. First verify whether exposed or business-critical assets run the affected versions, apply vendor fixes or mitigations, and preserve logs for review.
Comments
Moderated technical discussion. Read the community guidelines.
No comments yet.
Sign in or create an account to comment and suggest corrections.